Half-year report · HY
9218.TEDINET S100YWYW
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥6.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥294m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥277m | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥270m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥438m | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥254m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥270m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥255m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥139m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥255m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥156m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥139m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥156m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥5.7bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥5.4bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.1bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥3.8bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.6bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥910m | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥57m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥632m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥238m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥588m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥324m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥262m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥212m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥68m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥184m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥13.25 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.56 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.05 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.11 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.09 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 24.7% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2026-01-01 → 2026-06-30 | ¥84m |
| Otherother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥56m |
| Otherother segments | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥28m |
| Otherother segments | segment profit | 2026-01-01 → 2026-06-30 | −¥666,000 |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥29m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥29m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥462m |
| Medical Work Shift Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥1.9bn |
| Medical Work Shift Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥1.9bn |
| Medical Work Shift Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥125m |
| Mental Health Solution Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥2.1bn |
| Mental Health Solution Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥2.1bn |
| Mental Health Solution Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1m |
| Mental Health Solution Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥632m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥4.1bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥4.1bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥29m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥756m |
| Otherother segments | revenue | 2025-01-01 → 2025-06-30 | ¥86m |
| Otherother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥60m |
| Otherother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥25m |
| Otherother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥4m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥279m |
| Medical Work Shift Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Medical Work Shift Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Medical Work Shift Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥131m |
| Mental Health Solution Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Mental Health Solution Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Mental Health Solution Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥750,000 |
| Mental Health Solution Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥421m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥26m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥556m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 526
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | InterimDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes business combinations semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |